Literature DB >> 15820704

D-cycloserine facilitates extinction of learned fear: effects on reacquisition and generalized extinction.

Lana Ledgerwood1, Rick Richardson, Jacquelyn Cranney.   

Abstract

BACKGROUND: d-cycloserine (DCS) facilitates extinction of learned fear. The aim of this study was to examine whether DCS 1) affects reacquisition of fear (Experiment 1) and 2) produces generalized extinction of fear (Experiment 2).
METHODS: Following fear conditioning, where a light or a tone conditioned stimulus (CS) was paired with a white-noise burst unconditioned stimulus (US), rats received nonreinforced exposure to one CS (i.e., extinction training). Fear was assessed by measuring CS-elicited freezing, a species-specific defense response.
RESULTS: Rats given DCS exhibited facilitated extinction of fear but were able to reacquire fear of that CS in a similar manner as saline-treated control animals (Experiment 1). Furthermore, DCS-treated rats exhibited generalized extinction (i.e., they were less fearful of a non-extinguished CS) in comparison to controls (Experiment 2).
CONCLUSIONS: DCS facilitates extinction of learned fear to the extinguished CS, but also appears to reduce fear of a nonextinguished CS. These findings suggest that this drug may have substantial clinical value in the treatment of anxiety disorders.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15820704     DOI: 10.1016/j.biopsych.2005.01.023

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  86 in total

Review 1.  Pharmacological enhancement of drug cue extinction learning: translational challenges.

Authors:  K M Kantak; B Á Nic Dhonnchadha
Journal:  Ann N Y Acad Sci       Date:  2011-01       Impact factor: 5.691

Review 2.  Neural and cellular mechanisms of fear and extinction memory formation.

Authors:  Caitlin A Orsini; Stephen Maren
Journal:  Neurosci Biobehav Rev       Date:  2012-01-02       Impact factor: 8.989

Review 3.  Plastic synaptic networks of the amygdala for the acquisition, expression, and extinction of conditioned fear.

Authors:  Hans-Christian Pape; Denis Pare
Journal:  Physiol Rev       Date:  2010-04       Impact factor: 37.312

4.  Different mechanisms of fear extinction dependent on length of time since fear acquisition.

Authors:  Karyn M Myers; Kerry J Ressler; Michael Davis
Journal:  Learn Mem       Date:  2006 Mar-Apr       Impact factor: 2.460

Review 5.  Extinction: [corrected] does it or doesn't it? The requirement of altered gene activity and new protein synthesis.

Authors:  K Matthew Lattal; Jelena Radulovic; Ken Lukowiak
Journal:  Biol Psychiatry       Date:  2006-08-15       Impact factor: 13.382

6.  Secondary extinction in Pavlovian fear conditioning.

Authors:  Drina Vurbic; Mark E Bouton
Journal:  Learn Behav       Date:  2011-09       Impact factor: 1.986

7.  An unconditioned stimulus retrieval extinction procedure to prevent the return of fear memory.

Authors:  Jianfeng Liu; Liyan Zhao; Yanxue Xue; Jie Shi; Lin Suo; Yixiao Luo; Baisheng Chai; Chang Yang; Qin Fang; Yan Zhang; Yanping Bao; Charles L Pickens; Lin Lu
Journal:  Biol Psychiatry       Date:  2014-04-03       Impact factor: 13.382

8.  Effects of D-cycloserine on extinction and reconditioning of ethanol-seeking behavior in mice.

Authors:  Peter A Groblewski; K Matthew Lattal; Christopher L Cunningham
Journal:  Alcohol Clin Exp Res       Date:  2009-03-06       Impact factor: 3.455

9.  D-cycloserine and cocaine cue reactivity: preliminary findings.

Authors:  Kimber L Price; Aimee L McRae-Clark; Michael E Saladin; Megan M Moran-Santa Maria; Stacia M DeSantis; Sudie E Back; Kathleen T Brady
Journal:  Am J Drug Alcohol Abuse       Date:  2009       Impact factor: 3.829

10.  Vorinostat ameliorates impaired fear extinction possibly via the hippocampal NMDA-CaMKII pathway in an animal model of posttraumatic stress disorder.

Authors:  Yasutaka Matsumoto; Shigeru Morinobu; Shigeto Yamamoto; Tomoya Matsumoto; Shiro Takei; Yosuke Fujita; Shigeto Yamawaki
Journal:  Psychopharmacology (Berl)       Date:  2013-04-13       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.